Constellation Pharmaceuticals
About:
Constellation Pharmaceuticals develops drugs in the field of epigenetics focusing on selective regulators of its function.
Website: http://www.constellationpharma.com
Twitter/X: CPI_epigenetics
Top Investors: Hercules Capital, OrbiMed, Fidelity, Deerfield, Cormorant Asset Management
Description:
Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
$721M
Cambridge, Massachusetts, United States
2008-01-01
info(AT)constellationpharma.com
Danny Reinberg, David Allis, Yang Shi
101-250
2019-12-10
Public
© 2025 bioDAO.ai